Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
National Imaging Associates is a U.S. healthcare services company focused on specialty benefit management and prior authorization, historically best known for radiology benefits management. Founded in 1995, it built clinical and technology-enabled programs to help health plans manage the quality, appropriateness, and cost of advanced imaging and other specialty services. Over time, its scope expanded beyond imaging into areas such as cardiac, musculoskeletal, physical medicine, genetics, and radiation oncology utilization management. The business was acquired as part of the NIA/Magellan Specialty Health asset transaction announced by Evolent in 2022 and has since been rebranded under Evolent, with the former NIA provider portal continuing as RadMD. For a biotech or healthcare analyst, this is not a drug-development company but a commercial healthcare management organization embedded in payer-provider workflow.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Imaging Associates.